Invention Grant
- Patent Title: Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
-
Application No.: US16428767Application Date: 2019-05-31
-
Publication No.: US10669339B2Publication Date: 2020-06-02
- Inventor: James William West , Li Mei , Stephen James Moore , Margaret T. L. Nguyen , Daniel Robert Hostetter , Olga Vasiljeva , Jason Gary Sagert , Jonathan Alexander Terrett
- Applicant: CytomX Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: CYTOMX THERAPEUTICS, INC.
- Current Assignee: CYTOMX THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Fish & Richardson P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K49/00 ; A61K39/00
Abstract:
The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Public/Granted literature
- US20190382493A1 ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF Public/Granted day:2019-12-19
Information query
